UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000041676
Receipt No. R000045969
Scientific Title EUS-FNB wit or without on-site evaluation for the diagnosis of pancreatic tumor using novel 22G FNB needle: Prospective randomized controlled trial
Date of disclosure of the study information 2020/09/04
Last modified on 2020/09/04 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title EUS-FNB wit or without on-site evaluation for the diagnosis of pancreatic tumor using novel 22G FNB needle: Prospective randomized controlled trial
Acronym EUS-FNB with or without ROSE using 22G FNB needle: H2O study
Scientific Title EUS-FNB wit or without on-site evaluation for the diagnosis of pancreatic tumor using novel 22G FNB needle: Prospective randomized controlled trial
Scientific Title:Acronym EUS-FNB with or without ROSE using 22G FNB needle: H2O study
Region
Japan

Condition
Condition Pancreatic tumor
Classification by specialty
Hepato-biliary-pancreatic medicine
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Diagnostic yield
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Diagnostic yiled
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Maneuver
Interventions/Control_1 rapid on-site evaluation(ROSE)
Interventions/Control_2 macroscopic on-site evaluation(MOSE)
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria pancreatic tumor
Performance status <3
Key exclusion criteria contraindication of EUS-FNA
Target sample size 180

Research contact person
Name of lead principal investigator
1st name Takeshi
Middle name
Last name Ogura
Organization Osaka Medical College
Division name 2nd Department of Internal Medicine
Zip code 569-8686
Address 2-7 Daigakuchou, Takatsukishi, Osaka 569-8686, Japan
TEL 072-683-1221
Email oguratakeshi0411@yahoo.co.jp

Public contact
Name of contact person
1st name Takeshi
Middle name
Last name Ogura
Organization Osaka Medical College
Division name 2nd Department of Internal Medicine
Zip code 569-8686
Address 2-7 Daigakuchou, Takatsukishi, Osaka 569-8686, Japan
TEL 072-683-1221
Homepage URL
Email oguratakeshi0411@yahoo.co.jp

Sponsor
Institute Osaka Medical College
Institute
Department

Funding Source
Organization Osaka Medical College
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Osaka Medical College
Address 2-7 Daigakuchou, Takatsukishi, Osaka 569-8686, Japan
Tel 072-683-1221
Email oguratakeshi0411@yahoo.co.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 09 Month 04 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2020 Year 07 Month 23 Day
Date of IRB
2020 Year 08 Month 05 Day
Anticipated trial start date
2020 Year 08 Month 05 Day
Last follow-up date
2022 Year 07 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2020 Year 09 Month 04 Day
Last modified on
2020 Year 09 Month 04 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045969